Brochure | August 19, 2021

Cleavage And Deprotection Systems To Enhance Production Safety And Efficiency

Our mid- to large-scale C&D Systems allow you to automate the cleavage and deprotection steps while increasing productivity by freeing up your oligosynthesizer to focus on its core job of synthesis.

Solid phase synthesis using flow-through columns has become the proven method for reliably producing antisense, RNAi and other therapeutic oligonucleotides by manufacturers. After synthesis, the oligo must be cleaved from the solid support and conditioned for further downstream processing.

To streamline and automate this overlooked unit operation, Asahi Kasei Bioprocess offers a family of Cleavage and Deprotection (C&D) Systems for your clinical- and commercialscale oligonucleotide manufacturing needs.

Available in flow rates starting at 180 L/h up to 2000 L/h, C&D Systems are designed to accommodate both DNA and RNA processes.

VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: